Unbiased Analysis of Today's Healthcare Issues
Some key trends to watch from some of my colleagues at FTI in their article The Evolution of Healthcare: Trends to Watch in 2024. Commercialization of Healthcare. Over the past decade, private equity’s presence in the healthcare sector has significantly accelerated, with annual deal values soaring from $41.5 billion in 2010 to $119.9 billion in…
Using commercial claims data between 2009-2018, a paper in Health Services Research by Lalani et al (2024) finds that: Rebates are rising as a share of cost Fewer patients have $0 out-of-pocket cost Patient out-of-pocket costs growth was 2.9x as large as net drug cost growth Specifically: List prices increased 4.4%/yr (interquartile range [IQR], 1.1%…
My colleagues at FTI have a new white paper out surveying health care leaders on trends to expect in 2022. The data come from a survey of 251 senior decision makers working in corporate communications, investor relations, public affairs, business development, R&D and marketing for healthcare and life sciences companies in the U.S. Some key…
A recent AARP study uses 2017 data from IBM Marketscan to answer this question. Their data focuses on commercial and Medicare databases. They find that generic prices in 2017 fell by 9.3%. On the other hand, the price of specialty drug prices rose by 7%. The average annual cost of specialty drugs in the US…
In 2008, 38 percent of the federal government’s revenue was spent on health care. In 2009, however, this figure jumped to 54 percent of total revenues. Although federal health spending only increased by 17.9%, a decline in revenues of a similar magnitude caused this large change. Surprisingly, state and local spending on healthcare barely budged. In…